Skip to main content
Journal cover image

A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.

Publication ,  Journal Article
Goswami, ND; Tsalik, EL; Naggie, S; Miller, WC; Horton, JR; Pfeiffer, CD; Hicks, CB
Published in: Trials
January 22, 2014

BACKGROUND: The proportion of clinical research sponsored by industry will likely continue to expand as federal funds for academic research decreases, particularly in the fields of HIV/AIDS and hepatitis C (HCV). While HIV and HCV continue to burden the US population, insufficient data exists as to how industry sponsorship affects clinical trials involving these infectious diseases. Debate exists about whether pharmaceutical companies undertake more market-driven research practices to promote therapeutics, or instead conduct more rigorous trials than their non-industry counterparts because of increased resources and scrutiny. The ClinicalTrials.gov registry, which allows investigators to fulfill a federal mandate for public trial registration, provides an opportunity for critical evaluation of study designs for industry-sponsored trials, independent of publication status. As part of a large public policy effort, the Clinical Trials Transformation Initiative (CTTI) recently transformed the ClinicalTrials.gov registry into a searchable dataset to facilitate research on clinical trials themselves. METHODS: We conducted a cross-sectional analysis of 477 HIV and HCV drug treatment trials, registered with ClinicalTrials.gov from 1 October 2007 to 27 September 2010, to study the relationship of study sponsorship with randomized study design. The likelihood of using randomization given industry (versus non-industry) sponsorship was reported with prevalence ratios (PR). PRs were estimated using crude and stratified tabular analysis and Poisson regression adjusting for presence of a data monitoring committee, enrollment size, study phase, number of study sites, inclusion of foreign study sites, exclusion of persons older than age 65, and disease condition. RESULTS: The crude PR was 1.17 (95% CI 0.94, 1.45). Adjusted Poisson models produced a PR of 1.13 (95% CI 0.82, 1.56). There was a trend toward mild effect measure modification by study phase, but this was not statistically significant. In stratified tabular analysis the adjusted PR was 1.14 (95% CI 0.78, 1.68) among phase 2/3 trials and 1.06 (95% CI 0.50, 2.22) among phase 4 trials. CONCLUSIONS: No significant relationship was found between industry sponsorship and use of randomization in trial design in this cross-sectional study. Prospective studies evaluating other aspects of trial design may shed further light on the relationship between industry sponsorship and appropriate trial methodology.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Trials

DOI

EISSN

1745-6215

Publication Date

January 22, 2014

Volume

15

Start / End Page

31

Location

England

Related Subject Headings

  • Research Support as Topic
  • Research Design
  • Registries
  • Randomized Controlled Trials as Topic
  • Humans
  • Hepatitis C
  • Health Care Sector
  • HIV Infections
  • General & Internal Medicine
  • Data Mining
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goswami, N. D., Tsalik, E. L., Naggie, S., Miller, W. C., Horton, J. R., Pfeiffer, C. D., & Hicks, C. B. (2014). A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design. Trials, 15, 31. https://doi.org/10.1186/1745-6215-15-31
Goswami, Neela D., Ephraim L. Tsalik, Susanna Naggie, William C. Miller, John R. Horton, Christopher D. Pfeiffer, and Charles B. Hicks. “A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.Trials 15 (January 22, 2014): 31. https://doi.org/10.1186/1745-6215-15-31.
Goswami, Neela D., et al. “A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.Trials, vol. 15, Jan. 2014, p. 31. Pubmed, doi:10.1186/1745-6215-15-31.
Goswami ND, Tsalik EL, Naggie S, Miller WC, Horton JR, Pfeiffer CD, Hicks CB. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design. Trials. 2014 Jan 22;15:31.
Journal cover image

Published In

Trials

DOI

EISSN

1745-6215

Publication Date

January 22, 2014

Volume

15

Start / End Page

31

Location

England

Related Subject Headings

  • Research Support as Topic
  • Research Design
  • Registries
  • Randomized Controlled Trials as Topic
  • Humans
  • Hepatitis C
  • Health Care Sector
  • HIV Infections
  • General & Internal Medicine
  • Data Mining